Skip to main content

Cigna, CVS bolster EpiPen rivals

Cigna has stopped coverage for $600 EpiPens and CVS Pharmacy has dramatically lowered prices for a competing device with a different brand name.

Republish
Lead image for this article
Credit: Todd Wiseman / Becca Aaronson

The health insurance company Cigna stopped coverage for $600 EpiPens and pharmacy chain CVS dramatically lowered prices for a competing device with a different brand name, dealing a blow to the EpiPen maker Mylan. (CNBC)

You've read 2 articles this month. You have unlimited free articles remaining because we don't have a paywall.

Texans need truth. Help us report it.

Independent Texas reporting needs your support. The Texas Tribune delivers fact-based journalism for Texans, by Texans — and our community of members, the readers who donate, make our work possible. Help us bring you and millions of others in-depth news and information. Will you support our nonprofit newsroom with a donation of any amount?

Support independent Texas news

Become a member. Join today.

Choose an amount or learn more about membership.

$18 $20 $25 Other
Donate now

Information about the authors

Cassandra Pollock’s staff photo

Learn about The Texas Tribune’s policies, including our partnership with The Trust Project to increase transparency in news.

Explore related story topics

Read More

  • Loading recommendations for further reading
  • Loading indicatorLoading indicatorLoading indicator
  • Loading indicatorLoading indicatorLoading indicator
  • Loading indicatorLoading indicatorLoading indicator
  • Loading indicatorLoading indicatorLoading indicator